TY  - GEN
AU  - Ndrepepa,Gjin
AU  - Neumann,Franz-Josef
AU  - Deliargyris,Efthymios N
AU  - Mehran,Roxana
AU  - Mehilli,Julinda
AU  - Ferenc,Miroslaw
AU  - Schulz,Stefanie
AU  - Schömig,Albert
AU  - Kastrati,Adnan
AU  - Stone,Gregg W
TI  - Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials
SN  - 1941-7632
PY  - 2013///0402
KW  - Aged
KW  - Chi-Square Distribution
KW  - Coronary Thrombosis
KW  - blood
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fibrinolytic Agents
KW  - adverse effects
KW  - Hemorrhage
KW  - chemically induced
KW  - Heparin
KW  - Hirudins
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - Odds Ratio
KW  - Peptide Fragments
KW  - Percutaneous Coronary Intervention
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Randomized Controlled Trials as Topic
KW  - Recombinant Proteins
KW  - Recurrence
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCINTERVENTIONS.112.972869
ER  -